ClinConnect ClinConnect Logo
Search / Trial NCT01521910

Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy

Launched by STENO DIABETES CENTER COPENHAGEN · Jan 30, 2012

Trial Information

Current as of April 24, 2025

Completed

Keywords

Survival Protein Restriction Diabetic Nephropathy Type 1 Diabetes Gfr Esrd Progressive Renal Disease

ClinConnect Summary

The study was a prospective, randomized, unmasked, controlled trial carried out at the Steno Diabetes Center. With concealed randomization the patients were (in blocks of two according to the level of GFR) assigned to receive either a usual-protein diet or a low-protein diet.

After randomization an iso-caloric low-protein diet of 0.6 g/kg/day was prescribed to patients in the low-protein diet group. The usual-pro tein diet consisted of the patients' pre-study diet.

The planned duration of follow-up was four years, scheduled visits every three-months. All patients gave complete history of ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diabetes mellitus type 1
  • duration at least 10 years
  • onset before age of 35,
  • presence of diabetic retinopathy
  • albuminuria\>=300mg/24 h in at least 2/3 sterile urine samples
  • no clinical or laboratory evidence of other kidney or urinary tract disease
  • GFR above 20mL/min/1.73M2
  • pre-study decline in GFR\>= 2 mL/min/year
  • Exclusion Criteria:
  • pregnancy
  • history of congestive heart failure or myocardial infarction or coronary bypass surgery within the last three months

Trial Officials

Henrik P Hansen, MD

Principal Investigator

Steno Diabetes Center Copenhagen

About Steno Diabetes Center Copenhagen

Steno Diabetes Center Copenhagen is a leading clinical research facility dedicated to advancing the understanding and treatment of diabetes and its complications. As a prominent sponsor of clinical trials, the center focuses on innovative research that bridges clinical practice and scientific inquiry, fostering collaborations with healthcare professionals, researchers, and patients. Committed to improving patient outcomes, Steno Diabetes Center Copenhagen emphasizes evidence-based approaches and cutting-edge methodologies to enhance diabetes management and care, ultimately contributing to the global fight against this chronic disease.

Locations

Gentofte, , Denmark

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials